Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- MTNB quarterly accounts receivable is not available.
Performance
MTNB Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
MTNB Accounts Receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
MTNB Accounts Receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time |
Matinas BioPharma Holdings Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Jun 2018 | - | $89.80 K(+49.9%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | $59.90 K(+99.0%) |
Mar 2015 | - | $30.10 K |
FAQ
- What is the all time high quarterly accounts receivable for Matinas BioPharma Holdings?
What is the all time high quarterly accounts receivable for Matinas BioPharma Holdings?
Matinas BioPharma Holdings all-time high quarterly accounts receivable is $89.80 K